Recognition of Oral Appearances in Hypertensive Patients
Emad H Abdulla*, Mohammad M Hussein, Ghaith Safaa and Tabarak Ahmed
Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad
*Corresponding Author: Emad H Abdulla, Ibn Sina University of Medical and
Pharmaceutical Sciences, Iraq, Baghdad.
Received: September 30, 2022; Published: October 17, 2022
Background: High blood pressure (hypertension) is a common condition, eventually cause health problems, such as heart disease. 0ral surgery, placing dental implants, and periodontal surgery were more complicated in hypertensive patients. Aim: The present study is to determine the pattern of common oral lesion in an Iraqi hypertensive patient.
Materials and Methods: A total of 100 patients came to dental clinics of Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq, Baghdad. In April 2021 to May 2022, have be examined by the researchers. The study sample consist of 100 known as hypertensive patient. between the age group of 20-70 years of there are 57 patients males and 43 females.
Results: The hypertensive patients examined during the course of study belonged to the age group of 41-60 years. Around 18% of the patients under study presented with Ulceration. 12% with gingival bleeding. 14% presented with hypo salivation or xerostomia. 1% of the total patients presented with White oral lesion. 1% of patients presented with facial nerve palsy. 8% patients presented with gingival enlargement swelling. 2% have Periodontitis. 4% have TMJ Pain and 8% have Halitosis.
Conclusion: High blood pressure medications, similar to other drugs, can cause side effects and adverse reactions. It is important that the oral health care provider has an understanding of the different types of reactions they can cause. Oral manifestations associated with taking antihypertensive medications can range from dry mouth, alterations in taste, gingival enlargement, and lichenoid reactions.
Keywords:Hypertension; Oral Lesions; Oral Surgery; Antihypertensive Drugs; Xerostomia
- Whelton PK., et al. “ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelinesexternal icon”. Journal of the American College of Cardiology19 (2018): e127-e248.
- AV Chobanian., et al. “Theseventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report”. Journal of the American Medical Association19 (2003): 2560-2572.
- Habbab KM., et al. “Potentialoral manifestations of cardiovascular drugs”. Oral Diseases 8 (2010): 769-773.
- J Guggenheimer and PA Moore. “Xerostomia: etiology, recognition and treatment”. Journal of the American Dental Association1 (2003): 61-69.
- LM Wing., et al. “Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension”. European Journal of Clinical Pharmacology6 (1977): 463-469.
- J Breidthardt., et al. “Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension”. Clinical Autonomic Research6 (1993): 385-390.
- WW Herman., et al. “New national guidelines on hypertension: a summary for dentistry”. Journal of the American Dental Association5 (2004): 576-584.
- JS Ellis., et al. “Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study”. Journal of Periodontology1 (1999): 63-67.
- G Kaur., et al. “Association between calcium channel blockers and gingival hyperplasia”. Journal of Clinical Periodontology7 (2010): 625-630.
- T Tagawa., et al. “Marked gingival hyperplasia induced by nifedipine”. International Journal of Oral and Maxillofacial Surgery2 (1990): 72-73.
- L Fattore., et al. “Gingival hyperplasia: a side effect of nifedipine and diltiazem”. Special Care in Dentistry3 (1991): 107-109.
- RA Seymour. “Effects of medications on the periodontal tissues in health and disease”. Periodontology 20001 (2006): 120-129.
- M Mavrogiannis., et al. “The management of drug-induced gingival overgrowth”. Journal of Clinical Periodontology6 (2006): 434-439.
- SG Ciancio. “Medications’ impact on oral health”. Journal of the American Dental Association10 (2004): 1440-1480.
- P Ellgehausen., et al. “Drug-induced lichen planus”. Clinics in Dermatology3 (1998): 325-332.
- BH Ackerman and N Kasbekar. “Disturbances of taste and smell induced by drugs”. Pharmacotherapy3 (1997): 482-496.
- V Musumeci., et al. “Salivary electrolytes in treated hypertensives at low or normal sodium diet”. Clinical and Experimental Hypertension2 (1993): 245-256.
- Adeloye D., et al. “An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis”. Journal of Hypertension 2 (2015): 230-242.
- Ninios I., et al. “Gender-specific differences in hypertension prevalence, treatment, control, and associated conditions among the elderly: data from a Greek population”. Clinical and Experimental Hypertension (New York, NY: 1993) 30.5 (2008): 327-337.
- Uwah AF., et al. “Prevalence of hypertension among adults attending Faithbased Centres in Abak Township, Akwa Ibom State”. Nigeria Merit Research Journal of Medicine and Medical Sciences7 (2015): 245-248.
- Mittal BV and Singh AK. “Hypertension in the developing world: challenges and opportunities”. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation3 (2010): 590-598.
- Popescu SM., et al. “Hypertensive Patients and Their Management in Dentistry”. Hindawi Publishing Corporation (2013).
- Kumar P., et al. “Oral manifestations in hypertensive patients: A clinical study”. Journal of Oral and Maxillofacial Pathology: JOMFP2 (2012): 215-221.
- Gesko D., et al. “The Oral-Systemic Link: An Opportunity for Collaboration”. Diabetes Spectrum4 (2011): 187-189.
- Esra G., et al. “Oral health related quality of life and periodontal health status in patients undergoing haemodialysis”. JADA (2009): 140.
- Suliman N., et al. “Influence of oral mucosal lesions and oral symptoms on oral health related quality of life in dermatological patients: a cross sectional study in Sudan”. BMC Oral Health 12 (2012): 19.
- Banthia R., et al. “Is periodontal health a predictor of druginduced gingival overgrowth? A cross-sectional study”. Dental Research Journal5 (2014): 579-584.
- Pradhan S and Mishra P. “Gingival enlargement in antihypertensive medication”. JNMA; Journal of the Nepal Medical Association174 (2009): 14952.
- Joshi S and Bansal S. “A rare case report of amlodipine-induced gingival enlargement and review of its pathogenesis”. Case Reports in Dentistry 2013 (2013): 138248.
- Hedstrom L and Bergh H. “Sublingual varices in relation to smoking and cardiovascular diseases”. The British Journal of Oral and Maxillofacial Surgery2 (2010): 136-138.
- Nonzee V., et al. “Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications”. Journal of the Medical Association of Thailand Chotmaihet Thangphaet1 (2012): 96-104.
- Segura-Egea JJ., et al. “Hypertension and dental periapical condition”. Journal of Endodontics11 (2010): 1800-1804.
- MERWARTH HR. “The occurrence of peripheral facial paralysis in hypertensive vascular disease”. Annals of Internal Medicine2 (1942): 298-307.